Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients

CONCLUSION AND RELEVANCE: The data obtained from the TCIP are not static, immune control of CMV in latency can change and must be evaluated in clinical context. Timing of TCIP after transplant is significant, and patient-specific factors remain important to assess the likelihood of CMV in each unique patient-specific scenario. A CMV stewardship program can aid in application and interpretation of results.PMID:37897238 | DOI:10.1177/10600280231207899

Source: The Annals of Pharmacotherapy - October 28, 2023 Category: Drugs & Pharmacology Authors: Jillian L Descourouez Jeannina A Smith Christopher M Saddler Didier A Mandelbrot Jon S Odorico Margaret R Jorgenson Source Type: research